Latest: FDA Approves New Biosimilar for Oncology Treatment

Microneedling with tranexamic acid may improve outcomes for patients with melasma

0 Mins

1. Among patients with melasma, microneedling with tranexamic acid was superior to microneedling with metformin or the control treatment in reducing melasma severity and improving patient satisfaction. Evidence Rating Level: 2 (Good) Melasma is an acquired hyperpigmentation disorder most commonly affecting women. Its chronicity and high recurrence rate make it difficult to treat. Microneedling has […]

The post Microneedling with tranexamic acid may improve outcomes for patients with melasma first appeared on 2 Minute Medicine.
Tags:
📢

Advertisement

300x250 Banner

Recent Content

COPD Biologics: Early Treatment Insights

Pulmonology • 2 hours ago

Antihypertensive Medication Guidelines

Cardiology • 4 hours ago

Juvenile Arthritis Care Transition

Rheumatology • 6 hours ago